Global Oral Thin Film Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Thin Film Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Thin Film Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Thin Film Drugs market is projected to reach US$ 2677.2 million in 2034, increasing from US$ 1310.5 million in 2022, with the CAGR of 10.9% during the period of 2024 to 2034. Demand from Schizophrenia and Migraine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Thin Film Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Thin Film Drugs key manufacturers include Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma and Wolters Kluwer, etc. Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG are top 3 players and held % sales share in total in 2022.
Oral Thin Film Drugs can be divided into Sublingual Film and Fully Dissolving Dental/Buccal Film, etc. Sublingual Film is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Thin Film Drugs is widely used in various fields, such as Schizophrenia, Migraine, Opioid Dependence and Nausea & Vomiting, etc. Schizophrenia provides greatest supports to the Oral Thin Film Drugs industry development. In 2022, global % sales of Oral Thin Film Drugs went into Schizophrenia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Thin Film Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
Segment by Type
Sublingual Film
Fully Dissolving Dental/Buccal Film
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Thin Film Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Thin Film Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Thin Film Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Thin Film Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Thin Film Drugs introduction, etc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Thin Film Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Oral Thin Film Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Thin Film Drugs key manufacturers include Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG, ZIM Laboratories Limited, Indivior Plc., Allergan Plc., IntelGenx Corp, NAL Pharma and Wolters Kluwer, etc. Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Novartis AG are top 3 players and held % sales share in total in 2022.
Oral Thin Film Drugs can be divided into Sublingual Film and Fully Dissolving Dental/Buccal Film, etc. Sublingual Film is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Thin Film Drugs is widely used in various fields, such as Schizophrenia, Migraine, Opioid Dependence and Nausea & Vomiting, etc. Schizophrenia provides greatest supports to the Oral Thin Film Drugs industry development. In 2022, global % sales of Oral Thin Film Drugs went into Schizophrenia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Thin Film Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
Segment by Type
Sublingual Film
Fully Dissolving Dental/Buccal Film
Segment by Application
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Thin Film Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Thin Film Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Thin Film Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Thin Film Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Thin Film Drugs introduction, etc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Thin Film Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.